ArticleBMC bioinformatics2025
MLGCN-Driver: a cancer driver gene identification method based on multi-layer graph convolutional neural network.
Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThe progression of cancer is driven by the accumulation of mutations in driver genes. Many researches promote to identify cancer driver genes. However, most of them ignore the high-order features in the network.
resultIn this study, we propose a novel method MLGCN-Driver based on multi-layer graph convolutional neural networks (GCN) to boost driver gene identification. MLGCN-Driver employs multi-layer GCN with initial residual connections and identity mappings to learn biological multi-omics features within biological networks. In addition, node2vec algorithm is used to extract the topological structure features of the biological network, and then the features are fed into another multi-layer GCN for feature learning. Meanwhile, the initial residual connections and identity mappings mitigate the over-smooth of features. Finally, the probability of each gene being a driver gene is calculated based on low-dimensional biological features and topological features.
conclusionWe applied the MLGCN-Driver on pan-cancer dataset and cancer type-specific datasets. Experimental results demonstrate the excellent performance of MLGCN-Driver in terms of the area under the ROC curve (AUC) and the area under the precision-recall curve (AUPRC) when compared with state-of-the-art approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.